This solicitation closed on May 25, 2026
View current FOOD AND DRUG ADMINISTRATION opportunities →Progenesis QI Software Acquisition
AI Overview
Commercial perpetual software license acquisition for Progenesis QI proteomics analysis software supporting FDA laboratory operations.
This summary is AI-generated from the official solicitation.
Key Details
Official Description
Contractor shall provide one (1) commercial perpetual software license for Progenesis QI Software License. The scope includes delivery of the software, activation credentials, and applicable commercial documentation. This acquisition does not include system development, hosting services, contractor access to FDA systems, or ongoing managed services.
Change History
Progenesis QI Software Acquisition
New SAM.gov opportunity: Progenesis QI Software Acquisition
Similar Opportunities
Get Alerts for Opportunities Like This
RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.
Start Free Trial